ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,694Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 135

$622K Total Retail Price of All Prescriptions

Rank: 1 out of 135

803 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
17% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oregon
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

0% of this provider’s 8,934 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

12 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oregon
CARVEDILOL 713 647 1 1
ISOSORBIDE MONONITRATE ER 707 639 2 9
METOPROLOL SUCCINATE 438 413 3 3
FUROSEMIDE 437 400 4 4
SIMVASTATIN 426 392 5 5
CRESTOR 406 392 6 15
WARFARIN SODIUM 368 351 7 10
METOPROLOL TARTRATE 324 308 8 7
LISINOPRIL 311 284 9 2
AMLODIPINE BESYLATE 305 285 10 6
AMIODARONE HCL 273 258 11 21
FLECAINIDE ACETATE 267 254 12 24
ATORVASTATIN CALCIUM 248 232 13 8
DIGOXIN 241 229 14 12
SOTALOL 212 201 15 26
LOSARTAN POTASSIUM 198 190 16 11
RANEXA 185 162 17 28
POTASSIUM CHLORIDE 184 179 18 14
SPIRONOLACTONE 181 155 19 18
DILTIAZEM 24HR CD 176 166 20 33
DILTIAZEM ER 170 158 21 37
FENOFIBRATE 143 118 22 49
PRAVASTATIN SODIUM 142 130 23 17
PRADAXA 127 105 24 23
KLOR-CON 10 118 106 25 32
COREG CR 117 117 26 66
CLOPIDOGREL 114 106 27 13
HYDRALAZINE HCL 108 86 28 42
NITROSTAT 107 93 29 20
DIOVAN 106 89 30 40
DILTIAZEM 24HR ER 104 92 31 34
NIASPAN 101 92 32 41
RAMIPRIL 85 83 33 30
ZETIA 81 79 34 29
LOVASTATIN 75 61 35 27
ATENOLOL 68 61 36 16
PLAVIX 64 62 37 19
MULTAQ 58 58 38 38
GEMFIBROZIL 53 46 39 93
BYSTOLIC 53 46 39 25
TAZTIA XT 50 39 41 71
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.